-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $495

Benzinga·10/23/2026 13:18:10
Diffusion vocale
TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $465 to $495.